Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Profit After Tax (2018 - 2025)

Historic Profit After Tax for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to -$21.0 million.

  • Neurogene's Profit After Tax fell 364.05% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$85.1 million, marking a year-over-year decrease of 10280.64%. This contributed to the annual value of -$75.1 million for FY2024, which is 10691.14% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Profit After Tax is -$21.0 million, which was down 364.05% from -$22.0 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Profit After Tax ranged from a high of $13.7 million in Q4 2023 and a low of -$22.6 million during Q1 2025
  • Moreover, its 3-year median value for Profit After Tax was -$18.5 million (2024), whereas its average is -$15.1 million.
  • As far as peak fluctuations go, Neurogene's Profit After Tax crashed by 24291.78% in 2024, and later crashed by 364.05% in 2025.
  • Over the past 3 years, Neurogene's Profit After Tax (Quarter) stood at $13.7 million in 2023, then crashed by 242.92% to -$19.5 million in 2024, then decreased by 7.37% to -$21.0 million in 2025.
  • Its last three reported values are -$21.0 million in Q3 2025, -$22.0 million for Q2 2025, and -$22.6 million during Q1 2025.